The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the ...

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug ...

Nylon, the durable and elastic material, is like other plastics made from chemicals found in fossil fuels. Biodegradable ...

Researchers have developed a new method for growing T cells in the lab, allowing them to survive longer and fight cancer more effectively. This advancement, detailed in Cell Metabolism, could ...

SG Americas Securities LLC grew its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 796.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 54,921 shares of the ...

Osaka Metropolitan University scientists have developed an artificial photosynthesis technology that produces precursors of ...

Researchers employed direct infusion/liquid chromatography-tandem mass spectrometry in their exploration of the potential of ...

The following is a summary of “Metabolomic in severe traumatic brain injury: exploring primary, secondary injuries, diagnosis, and severity,” published in the January 2025 issue of Critical Care by ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...